EN
登录

YesCare加入了阿片类药物使用的领先多机构倡议

YesCare has Joined Leading Multiagency Initiative on Opioid Use

businesswire 等信源发布 2024-04-02 18:30

可切换为仅中文


MONTGOMERY, Ala.--(BUSINESS WIRE)--YesCare, pioneer and foremost provider of correctional healthcare in the United States as a company built on more than 40 years of innovation and earned expertise in the industry, has in partnership with the Alabama Department of Corrections (ADOC) been named to the Substance Abuse and Mental Health Services Administration (SAMHSA) Policy Academy on Advancing Medication for Opioid Use Disorders in State Prisons..

阿拉巴马州蒙哥马利市——(商业新闻短讯)——YesCare是美国惩教保健的先驱和最重要的提供者,作为一家建立在40多年创新基础上并在该行业获得专业知识的公司,与阿拉巴马州惩教部(ADOC)合作,被提名为物质滥用和心理健康服务管理局(SAMHSA)政策学院,以促进州立监狱中阿片类药物使用障碍的药物治疗。。

This multiagency initiative focused on Medication Assisted Treatment (MAT) in prisons will be a collaboration led by SAMHSA (the federal agency charged with advancing behavioral health since 1992) along with YesCare, ADOC, the Alabama Department of Mental Health, the Alabama Board of Pardons and Parole, and the State Opioid Treatment Authority..

这项针对监狱药物辅助治疗(MAT)的多机构倡议将由SAMHSA(自1992年以来负责促进行为健康的联邦机构)与YesCare,ADOC,阿拉巴马州精神卫生部,阿拉巴马州赦免和假释委员会以及州阿片类药物治疗管理局共同领导。。

SAMHSA said in a statement, “SAMHSA's Policy Academy on Advancing Medication for Opioid Use Disorders (MOUD) in State Prisons underscores the critical importance of states providing this lifesaving treatment to people throughout their incarceration. The Policy Academy is a part of the Biden-Harris Administration's efforts to address the opioid overdose epidemic and to support recovery among Americans experiencing substance use disorders.

萨姆萨在一份声明中说,“萨姆萨关于在州立监狱中推进阿片类药物使用障碍(MOUD)药物治疗的政策学院强调了各州在监禁期间为人们提供这种挽救生命的治疗的重要性。该政策学院是拜登·哈里斯(Biden Harris)政府努力解决阿片类药物过量流行问题并支持经历药物使用障碍的美国人康复的一部分。

SAMHSA is pleased to be working with the 10 participating state departments of corrections to help them implement or expand access to MOUD across their facilities.”.

SAMHSA很高兴与10个参与的州惩戒部门合作,帮助他们在其设施中实施或扩大对MOUD的访问。”。

MAT is defined as the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders.

MAT的定义是使用药物,结合咨询和行为疗法,为整个患者提供治疗物质使用障碍的方法。

“Through this partnership, Alabama will be on the leading edge of MAT implementation, and success here will allow for an optimized roll out of improved programs nationwide,” said Jeff Sholey, CEO of YesCare. “To be selected by SAMHSA for this initiative reflects a true testament to the partnership we share with ADOC, and the common dedication we have in helping those with Opioid Use Disorders.

YesCare首席执行官杰夫·肖利(Jeff Sholey)表示:“通过这种合作关系,阿拉巴马州将处于MAT实施的前沿,这里的成功将使改进项目在全国范围内得到优化推广。”。“被SAMHSA选中参加这项活动,真实地证明了我们与ADOC的伙伴关系,以及我们在帮助阿片类药物使用障碍患者方面的共同奉献精神。

Alabama is truly positioning itself to be the national standard in this space.”.

阿拉巴马州真正将自己定位为这一领域的国家标准。”。

“We are proud to be a partner in this ongoing fight against addiction and drug abuse inside the state’s correctional facilities,” said John Hamm, ADOC Commissioner. “Partners like YesCare who are committed to actionable solutions are imperative to success and improved outcomes in Alabama.”

ADOC专员约翰·哈姆(JohnHamm)表示:“我们很自豪能成为该州惩教设施内正在进行的打击成瘾和药物滥用的合作伙伴。”。“像YesCare这样致力于可行解决方案的合作伙伴对于阿拉巴马州的成功和改善成果至关重要。”

Steve Tomlin, YesCare’s Chief Strategic Officer, added, “The prevalence of opioid use disorder in correctional facilities presents multifaceted challenges at the complex intersection of public health and criminal justice. Our goal is to use opportunities like this to further advance our model into the national model that delivers the best results throughout incarcerated populations.”.

YesCare的首席战略官Steve Tomlin补充道:“在公共卫生和刑事司法的复杂交叉点上,惩教设施中阿片类药物使用障碍的普遍存在带来了多方面的挑战。我们的目标是利用这样的机会,进一步将我们的模式推进到全国模式,在整个监禁人群中取得最佳效果。”。

Added Tomlin, “YesCare’s work in MAT has been heralded as a national model and gold standard in service. We believe further increasing MAT programs in Alabama’s prisons will reduce recidivism, improve post-release reintegration, increase public safety, and lower societal costs associated with reincarceration often attributed to opioid use disorder.”.

Tomlin补充道,“YesCare在MAT方面的工作被誉为国家典范和服务的黄金标准。我们相信,在阿拉巴马州监狱中进一步增加MAT项目将减少累犯,改善释放后的重返社会,提高公共安全,并降低与阿片类药物使用障碍相关的再监禁相关的社会成本。”。

YesCare has continually innovated with MAT to combat the opioid epidemic. It previously created training, via Lean Six Sigma, to increase proficiency with withdrawal protocols and MAT Maintenance/Induction processes. Training includes healthcare professionals as well as our correctional partners. Patient education and reentry services provide our patients with the tools and resources that are essential in managing their addiction..

YesCare不断创新MAT来对抗阿片类药物的流行。它之前通过精益六西格玛创建了培训,以提高退出协议和MAT维护/入职流程的熟练程度。培训包括医疗保健专业人员以及我们的惩教合作伙伴。患者教育和再入服务为我们的患者提供了管理他们成瘾所必需的工具和资源。。

For more information on YesCare, please visit yescarecorp.com.

有关YesCare的更多信息,请访问yescarecorp.com。

About YesCare

关于YesCare

YesCare is an industry leader providing comprehensive healthcare and reentry services to incarcerated individuals. For over 40 years, YesCare has provided expert medical, dental, and behavioral health services to more than 1 million patients at 475 correctional facilities across the country. Its mission is to provide exceptional care, put patient's health and safety first, and break the cycle of recidivism while helping to improve the communities where they live and work..

YesCare是一家为被监禁人员提供全面医疗保健和重返社会服务的行业领导者。40多年来,YesCare为全国475所惩教机构的100多万患者提供了专业的医疗、牙科和行为健康服务。它的使命是提供特殊护理,将患者的健康和安全放在首位,打破累犯循环,同时帮助改善他们生活和工作的社区。。